$434.6 Million Worldwide Preimplantation Genetic Testing Industry to 2027 - Impact of COVID-19 on the Market
Dublin, April 27, 2021 (GLOBE NEWSWIRE) -- The "Preimplantation Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Preimplantation Genetic Testing estimated at US$434.6 Million in the year 2020, is projected to reach a revised size of US$775.1 Million by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027.
Reagents & Consumables, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$408.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $128.7 Million, While China is Forecast to Grow at 8% CAGR
The Preimplantation Genetic Testing market in the U.S. is estimated at US$128.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$134.4 Million by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.
Software & Services Segment to Record 8.3% CAGR
In the global Software & Services segment, USA, Canada, Japan, China and Europe will drive the 8.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$72.9 Million in the year 2020 will reach a projected size of US$128 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$89.4 Million by the year 2027.
Select Competitors (Total 34 Featured):
Ariosa Diagnostics
Bioarray S.L.
California Pacific Medical Center (CPMC)
CombiMatrix
CooperSurgical, Inc.
F. Hoffmann-La Roche Ltd.
Genea Limited
Genesis Genetics
Good Start Genetics, Inc.
IGENOMIX
Illumina, Inc.
Invitae Corporation
Laboratory Corporation of America Holdings
Natera, Inc.
Oxford Gene Technology
PerkinElmer Inc.
Quest Diagnostics Incorporated
Reproductive Genetic Innovations, LLC
Reprogenetics
RHS Ltd.
Sequenom
Thermo Fisher Scientific, Inc.
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
IV. COMPETITION
Total Companies Profiled: 34
For more information about this report visit https://www.researchandmarkets.com/r/sojjxf
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900